CHE Stock Analysis: Buy, Sell, or Hold?
CHE - Chemed Corporation
$432.09
5.88 (1.38%)
▲
5d:
+1.84%
30d:
+12.85%
90d:
-8.69%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CHE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$621.71
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$386.03
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $432.08, which is considered extended relative to its 30-day fair value range of $384.56 to $426.08. The stock's valuation (Forward PE: 15.8) is in line with its historical norms (16.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CHE is in a downtrend. The price is approaching resistance at $434.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is in a downtrend. The price is approaching resistance at $434.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$384.56 -
$426.08
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($446.50)
Trading Range Analysis
30-Day Trading Range
$384.56 -
$426.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$404.26
Resistance Level
$434.18
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.84
Wall Street Target
$446.50
(+4.8%)
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
-0.4%
Profit Margin
10.2%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
15.8 vs 16.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$422.37
(-1%)
2-Year Target
$418.57
(-2%)
3-Year Target
$414.81
(-3%)
3-Yr Target (if PE normalizes)
(PE: 16→16)
$426.90
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 10.5%)
$800.27
(+88%)
Base:
(SPY PE: 15.8, Growth: 10.5%)
$575.09
(+35%)
Bear:
(PE: 13.5, Growth: 10.5%)
$488.82
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 23.15 | Current EPS (TTM): $18.32
Bull Case
$685.15
(+61%)
Analyst growth 46.9%, PE expands to 25.5
Base Case
$622.87
(+46%)
Market implied 46.9%, PE stable at 23.2
Bear Case
$288.35
(-32%)
Severe decline -20.0%, PE contracts to 19.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.8 to 16.3
Stabilization Target:
$438.63
(+2.9%)
PE Expansion Potential:
+2.9%
Share & Embed Analysis
Last updated: May 15, 2026 11:39 AM ET
Data refreshes hourly during market hours. Next update: 12:39 PM
Data refreshes hourly during market hours. Next update: 12:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin J Mcnamara
SELL
2000 shares
2026-03-12
Kevin J Mcnamara
SELL
2000 shares
2025-11-24
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |